DART ROBINHOOD THINGS TO KNOW BEFORE YOU BUY

Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs aimed at increasing the horizons of cytokine-based immunotherapy, specifically for cancers where cure choices remain limited. Use the links below to learn additional about our portfolio of cytokine-based immunotherapy candida